40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Analyze DCF forecasts for the company and compare them with competitors.
8.66B
Better than CRK's revenue of 1.85B.
42.24%
Worse than CRK's revenue growth rate of 115.65%.
2.79B
Better than CRK's ebitda of 457.55M.
32.24%
Better than CRK's ebitda margin of 24.72%.
1.58B
Better than CRK's ebit of -11.84M.
18.24%
Better than CRK's ebit margin of -0.64%.
1.21B
Worse than CRK's depreciation of 469.39M.
195.00M
Better than CRK's total cash of 30.66M.
2.25%
Better than CRK's cash as percentage of revenue of 1.66%.
1.30B
Worse than CRK's receivables of 267.74M.
14.97%
Worse than CRK's receivables as percentage of revenue of 14.47%.
9.00M
Worse than CRK's inventories of 5.01M.
0.10%
Better than CRK's inventories as percentage of revenue of 0.27%.
328.00M
Worse than CRK's accounts payable of 314.57M.
3.79%
Better than CRK's payables as percentage of revenue of 17.00%.
-1.52B
Better than CRK's capital expenditure of -689.21M.
-17.54%
Worse than CRK's capex as percentage of revenue of -37.24%.
12.25%
Worse than CRK's weighted average cost of capital (wacc) of 6.49%.
16.87%
Worse than CRK's cost of equity of 6.67%.
5.31%
Better than CRK's cost of debt of 6.23%.
2.64
Worse than CRK's beta of 0.48.
263.90M
Better than CRK's diluted shares outstanding of 276.81M.
6.68B
Worse than CRK's total debt of 2.71B.
10.03B
Better than CRK's total equity of 4.25B.
16.71B
Better than CRK's total capital of 6.97B.
39.98%
Worse than CRK's debt weighting of 38.96%.
60.02%
Worse than CRK's equity weighting of 61.04%.
1.80B
Better than CRK's ebiat of -12.42M.
1.10B
Better than CRK's unlevered free cash flow of -300.85M.
0.50%
Equal to CRK's long-term growth rate of 0.50%.
-12.22B
Worse than CRK's terminal value of 520.34M.
-10.85B
Worse than CRK's enterprise value of 307.11M.
6.68B
Worse than CRK's net debt of 2.70B.
-17.53B
Worse than CRK's equity value of -2.39B.
-66.42
Worse than CRK's equity value per share of -8.64.
Analyze analyst forecasts for the company and compare them with competitors.
10.86B
Better than CRK's estimated revenue of 249.51M.
2.27B
Better than CRK's estimated ebitda of -28.82M.
15.09
Better than CRK's estimated eps of -3.16.
1.50B
Better than CRK's estimated net income of -31.77M.
2.12B
Better than CRK's estimated ebit of -29.08M.
409.84M
Worse than CRK's estimated sg&a expense of 31.84M.
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Analysts expect the stock price to increase by 27.11%.
Buy
Positive consensus among analysts.
